Wyss InstituteLung Disease – Wyss Institute

COPDx: Rapid diagnostic to triage acute exacerbations

Seth Kroll — Wed, 09 Jul 2025 19:12:25 +0000

Chronic obstructive pulmonary disease (COPD) affects 15.9 million U.S. adults, and costs $49 billion annually to treat and manage. When COPD patients are exposed to lung irritants like viral or bacterial infections, air pollution, or smoke, it can trigger an acute exacerbation (AE), in which their symptoms quickly become more severe. AE is the leading cause of mortality and emergency hospital…

Source

Blood Clot Dx

admin — Wed, 09 Jul 2025 17:00:40 +0000

Blood clots can arise anywhere in the body, blocking blood flow and causing pain and other symptoms. The most serious types of clots, called deep vein thrombosis (DVT), typically form in the veins in the legs, and can break off and become lodged in a lung. This can cause a pulmonary embolism (PE), which is when blood flow to the lungs is prevented and can be fatal. The symptoms of PE resemble…

Source

Feyisayo (Sayo) Eweje on Helping Gene Therapies ENTER The Right Cells

Jessica Leff — Thu, 29 May 2025 13:00:47 +0000

The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as professionals, and their collaborations at the Wyss Institute and beyond. Sayo Eweje loves finding solutions, whether he’s looking at a Rubik’s Cube or a technical challenge in the lab. When faced with the problem of how to impact patients at both a personal and…

Source

ENTERing a new era of drug delivery

Jessica Leff — Thu, 15 May 2025 13:25:50 +0000

By Lindsay Brownell (BOSTON) — Getting medicines into the cells they’re designed to treat is a perennial problem for the medicine and pharmaceutical industries, and patients often suffer from side effects and ineffective treatments as a result. Current drug delivery vehicles carry a host of risks and limits: lipid nanoparticles can cause immune reactions and accumulate in the liver…

Source

Collaborative asthma project between Brigham and Women’s Hospital and the Wyss Institute advances with new grant support

Jessica Leff — Mon, 16 Dec 2024 15:55:41 +0000

By Benjamin Boettner (BOSTON) – Asthma affects more than 260M people worldwide and nearly 28M people in the U.S. alone, where, on average, 10 people die from attacks of the chronic disease each day. Many of these deaths could be prevented if patients had timely access to the appropriate therapy following an accurate diagnosis. Driven by an acute sense of urgency to close this diagnostic gap…

Source

Alex Plesa on Reversing Aging

Jessica Leff — Thu, 30 May 2024 13:00:18 +0000

The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as professionals, and their collaborations at the Wyss Institute and beyond. Most people believe that declining health as we age is an unfortunate, inevitable fact of life – but not Alex Plesa. He thinks the reason we think we can’t change it is because we don’t…

Source

The Wyss Institute’s 2024-2025 Validation Projects

Jessica Leff — Wed, 29 May 2024 14:55:23 +0000

Every year the Wyss Institute names a class of Validation Projects whose teams receive dedicated funding, business development support, and other resources to advance their promising technologies towards commercialization. They also collaborate with key opinion leaders, investors, and potential customers to de-risk their innovations and speed their progress to the market. This year…

Source

Emilia Javorsky on Finding Treatments for Radiation-Induced Lung Injury

Jessica Leff — Wed, 24 Jan 2024 14:00:59 +0000

The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as professionals, and their collaborations at the Wyss Institute and beyond. While attending medical school, Emilia Javorsky realized how infrequently research actually becomes new, effective therapies for patients. So, she decided to pursue translational research…

Source

Erik Aznauryan on Curative Treatment of Genetic Diseases

Jessica Leff — Wed, 16 Aug 2023 13:40:30 +0000

The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as scientists, and their collaborations at the Wyss Institute and beyond. Growing up with an ophthalmologist as a father, Erik Aznauryan’s interest in medicine began at a young age. Eventually, he realized that the scientific aspects of medicine interested him far…

Source

How do we make safer and more effective drugs?

Jessica Leff — Mon, 12 Jun 2023 15:14:20 +0000

Wyss researchers are using an ever-growing number of human tissue-mimicking Organ Chips to improve and accelerate the drug development process for a wide number of unmet diseases – and understand what causes them to erupt. More recently, they added a human Vagina Chip and personalized Barrett’s esophagus Chip to their arsenal, and created in vitro models of inflammatory bowel disease in children…

Source